Kangmei Pharmaceutical Co Ltd (600518) — Cash Flow-to-Debt Ratio
Kangmei Pharmaceutical Co Ltd (600518) has a Cash Flow-to-Debt Ratio of 0.03x as of September 2025, meaning its operating cash flow of CN¥219.96 Million could theoretically repay 0% of its total liabilities (CN¥6.46 Billion) in one year. See Kangmei Pharmaceutical Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Kangmei Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (1999–2024)
Historical debt coverage capacity for Kangmei Pharmaceutical Co Ltd across 26 annual periods. Also explore 600518 net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Kangmei Pharmaceutical Co Ltd (1999–2024)
Year-by-year debt coverage analysis for Kangmei Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see 600518 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.06x | CN¥-427.63 Million | CN¥6.59 Billion | ▼ -47.2% |
| 2023 | -0.04x | CN¥-317.52 Million | CN¥7.20 Billion | ▲ +51.9% |
| 2022 | -0.09x | CN¥-749.96 Million | CN¥8.18 Billion | ▼ -360.3% |
| 2021 | 0.04x | CN¥214.21 Million | CN¥6.09 Billion | ▲ +49.3% |
| 2020 | 0.02x | CN¥1.03 Billion | CN¥43.74 Billion | ▼ -64.0% |
| 2019 | 0.07x | CN¥2.88 Billion | CN¥43.94 Billion | ▲ +909.4% |
| 2018 | 0.01x | CN¥305.62 Million | CN¥47.03 Billion | ▲ +104.9% |
| 2017 | -0.13x | CN¥-4.84 Billion | CN¥36.78 Billion | ▼ -308.8% |
| 2016 | 0.06x | CN¥1.60 Billion | CN¥25.44 Billion | ▲ +138.6% |
| 2015 | 0.03x | CN¥508.86 Million | CN¥19.27 Billion | ▼ -74.0% |
| 2014 | 0.10x | CN¥1.13 Billion | CN¥11.16 Billion | ▼ -38.1% |
| 2013 | 0.16x | CN¥1.67 Billion | CN¥10.22 Billion | ▲ +19.8% |
| 2012 | 0.14x | CN¥1.01 Billion | CN¥7.38 Billion | ▲ +42.4% |
| 2011 | 0.10x | CN¥574.96 Million | CN¥5.99 Billion | ▼ -52.9% |
| 2010 | 0.20x | CN¥669.19 Million | CN¥3.28 Billion | ▲ +231.9% |
| 2009 | 0.06x | CN¥119.47 Million | CN¥1.95 Billion | ▲ +2532.9% |
| 2008 | 0.00x | CN¥3.02 Million | CN¥1.29 Billion | ▼ -98.7% |
| 2007 | 0.18x | CN¥162.55 Million | CN¥882.71 Million | ▲ +106.6% |
| 2006 | 0.09x | CN¥68.32 Million | CN¥766.30 Million | ▼ -85.5% |
| 2005 | 0.62x | CN¥133.13 Million | CN¥216.45 Million | ▲ +168.0% |
| 2004 | 0.23x | CN¥78.52 Million | CN¥342.09 Million | ▼ -22.8% |
| 2003 | 0.30x | CN¥78.02 Million | CN¥262.25 Million | ▲ +32.6% |
| 2002 | 0.22x | CN¥53.47 Million | CN¥238.35 Million | ▲ +118.1% |
| 2001 | 0.10x | CN¥15.69 Million | CN¥152.51 Million | ▲ +31.4% |
| 2000 | 0.08x | CN¥9.96 Million | CN¥127.27 Million | ▼ -70.0% |
| 1999 | 0.26x | CN¥30.25 Million | CN¥115.77 Million | — |